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Introduction
The simultaneous detection of  the expression patterns for tens of  thousands of  genes in patient samples 
can provide valuable insights into disease pathogenesis. In infectious disease, analysis of  gene expression 
profiles has provided an understanding of  host immune responses with the potential to improve diagno-
sis, develop vaccines, and design new therapies (1–3). Leprosy offers an attractive model for investigating 
immune pathways of  host defense and disease pathogenesis (4), as the disease forms a spectrum in which 
clinical manifestations correlate with the type of  immune response. At one end of  the spectrum, tubercu-
loid leprosy (T-lep) is characterized by few skin lesions containing few bacilli, i.e., paucibacillary (PB), and 
is typically self-limited, indicating that the immune response is containing the infection. At the opposite 
end of  the spectrum, lepromatous leprosy (L-lep), patients have many lesions containing numerous bacil-
li, i.e., multibacillary (MB), and, if  untreated, this form of  the disease is progressive, indicating that the 
immune response is ineffective.
The various forms of  leprosy enable the study of  disease complications, as the disease spectrum is 
not static and patients can develop various types of  inflammatory and pathologic reactions, either sponta-
neously or during therapy. These reactions, “reversal reactions” (RR, also known as “type 1 reactions”) (5) 
and erythema nodosum leprosum (ENL, also known as a “type 2 reaction”) (6), provide a window into 
Transcriptome profiles derived from the site of human disease have led to the identification of 
genes that contribute to pathogenesis, yet the complex mixture of cell types in these lesions has 
been an obstacle for defining specific mechanisms. Leprosy provides an outstanding model to 
study host defense and pathogenesis in a human infectious disease, given its clinical spectrum, 
which interrelates with the host immunologic and pathologic responses. Here, we investigated 
gene expression profiles derived from skin lesions for each clinical subtype of leprosy, analyzing 
gene coexpression modules by cell-type deconvolution. In lesions from tuberculoid leprosy 
patients, those with the self-limited form of the disease, dendritic cells were linked with MMP12 
as part of a tissue remodeling network that contributes to granuloma formation. In lesions from 
lepromatous leprosy patients, those with disseminated disease, macrophages were linked with 
a gene network that programs phagocytosis. In erythema nodosum leprosum, neutrophil and 
endothelial cell gene networks were identified as part of the vasculitis that results in tissue injury. 
The present integrated computational approach provides a systems approach toward identifying 
cell-defined functional networks that contribute to host defense and immunopathology at the site 
of human infectious disease.
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the dynamic immune events associated with mechanisms 
of  immunoregulation and immune-mediated tissue inju-
ry in human disease. RR is generally considered to rep-
resent a naturally occurring delayed-type hypersensitivity 
response to Mycobacterium leprae antigens; RR is associ-
ated with clearance of  bacilli from lesions, enhanced 
cell-mediated immunity against the pathogen resulting 
in inflammation, and an upgrade from the lepromatous 
pole toward the tuberculoid pole (7–11). RR is character-
ized as an inflammatory reaction characterized by ery-
thema, edema, and induration of  existing lesions, with 
associated neuritis (5, 12). ENL is thought to be mediat-
ed by immune complex deposition (13) but also involves 
IL-1 secretion, which can trigger neutrophil recruitment 
(14). ENL lesions are characterized as subcutaneous 
erythematous nodules, with systemic symptoms such 
as fever, arthritis, and neuritis (12). Because leprosy is a 
disease localized to skin, analysis of  the gene expression 
dynamics in biopsy specimens from leprosy skin lesions 
has provided new insights into human immune responses 
at the site of  infection that are often not possible to study in other conditions, such as tuberculosis and 
some autoimmune diseases.
Previously, investigation of  the gene expression profiles from leprosy lesions has been limited to the 
comparison of  specific subgroups or the grouping of  all leprosy patients in comparison to 15 other infec-
tious, inflammatory, and neoplastic skin diseases (15). Here, we investigated the specific genes and path-
ways associated with immune cell types that contribute to host defense and tissue injury at the site of  infec-
tion in the different subtypes of  leprosy. The approach we used was motivated by the observation that these 
lesions differ in the relative abundance and states of  specific cell types. Therefore, to characterize the gene 
expression differences between disease subtypes and reactions, it is essential to leverage existing cell-type 
and inflammatory signatures and overlay these with well-characterized immune pathways. We synthesize 
these observations using multipartite networks that reveal the interconnectivity among individual genes, 
pathways, and cell types.
Results
Gene expression profiles derived from leprosy lesions. Lesional biopsy samples (n = 29) from patients with the fol-
lowing leprosy subtypes were obtained for determination of  gene expression profiles and analysis of  gene 
subtype profiles: L-lep (n = 6), T-lep (n = 10), RR (n = 7), and ENL (n = 6) (Tables 1 and 2 and Supplemen-
tal Figure 1; supplemental material available online with this article; doi:10.1172/jci.insight.88843DS1). 
Although obtained simultaneously with the ENL profiles, the T-lep, L-lep, and RR gene expression profiles 
were previously published (15). All T-lep and L-lep lesions were obtained before the onset of  chemothera-
py. Gene expression profiles were derived via Affymetrix HG U133 Plus 2.0 microarrays and normalized 
Figure 1. Differential distribution of leprosy subtypes. (A) 
Unsupervised principal component analysis (PCA) of 29 leprosy 
biopsy specimens. Frozen RMA–normalized and filtered gene 
expression profiles from 29 leprosy biopsy specimens were char-
acterized using PCA and displayed, with each profile displayed 
as a colored sphere and individual identification. Ellipsoids rep-
resent the 95% confidence interval for sample distribution. Total 
3-dimensional PCA mapping represents 56% of variance (PC1 = 
29.5%; PC2 = 16.1%, and PC3 = 10.3%). (B) Unsupervised hierar-
chical clustering of leprosy biopsy specimens. Gene expression 
profiles from A were clustered using average Pearson correlation 
and displayed in a tree, with each terminal leaf representing a 
biopsy sample. ENL, erythema nodosum leprosum; L-lep, lepro-
matous leprosy; RR, reversal reaction; T-lep, tuberculoid leprosy.
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using frozen robust multiarray average (fRMA), as previously described (16).
Principal component analysis (PCA) of  the gene expression profiles demonstrated separation of  the 
leprosy samples into three groups enriched for L-lep, ENL, and T-lep/RR (Figure 1A). The T-lep and 
RR forms of  the disease clustered together, which prevented separation of  the two forms by clustering, 
in line with previous results (16). Although the gene expression profiles of  these subforms of  leprosy 
overlapped, the RR samples showed a greater heterogeneity, as indicated by the size of  the ellipsoid that 
represents the 95% confidence interval. The heterogeneity of  the RR samples may relate to differences 
in the severity and/or duration of  the reactional state or intrinsic host ability to respond, as was also 
observed for RR blood samples (17). It is noteworthy that the histologic differentiation of  T-lep and RR 
forms is often difficult (18, 19). In contrast, the ENL samples formed a separate group that was equally 
dissimilar to both the L-lep and T-lep/RR clusters. RR7 was located near the ENL samples.
Hierarchical clustering using average linkage again showed three distinct subtype groups of  L-lep, 
Figure 2. Cell-type–specific enrichment (deconvolution). (A) Cell-type–specific deconvolution of all leprosy clinical subtypes. For each of 19 immune cell–
type–specific signatures, signature enrichment scores were calculated using average gene expression for each leprosy subtype and normalized to Z scores. 
Each Z score represents the enrichment for a particular immune cell–type signature in the gene expression profile of one leprosy subtype relative to the 
other subtypes. Enrichment profiles for each condition were clustered using Euclidean distance and displayed in a heatmap, for which columns correspond 
to leprosy subtypes and rows correspond to cell types. Each individual square corresponds to the enrichment for one immune cell type in a specific leprosy 
subtype, with darker squares indicating higher enrichment. (B) Cell-type deconvolution of the proportional median lists for all leprosy subtypes. The gene 
count represents the number of genes in the proportional median list that overlapped with the specific cell-type list. ENL, erythema nodosum leprosum; 
L-lep, lepromatous leprosy; RR, reversal reaction; T-lep, tuberculoid leprosy.
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ENL, and T-lep/RR (Figure 1B). There were a few exceptions to the overall clustering pattern; three non-
ENL samples (2 T-lep, 1 RR) clustered with an ENL sample on a branch adjacent to the other ENL sam-
ples, although the relative distance of  these three samples to the ENL group was great, consistent with the 
distant branch points in the dendrogram. Furthermore, of  these three possible outliers, only one, RR7, was 
located in the near vicinity of  the ENL cluster by PCA analysis. Moreover, the PCA analysis used a subset 
of  genes used for hierarchal clustering, filtered by a coefficient of  variance of  ≥ 1.0. There was no clinical 
information to suggest that the three potential outliers were distinct.
Proportional median signatures. In order to identify genes that were highly expressed in one subtype rela-
tive to all others, we calculated proportional median values for all filtered probe sets in every subtype (Sup-
plemental Table 1). Briefly, the proportional median is a measure for comparing three or more conditions 
(15), and it is calculated for each probe set in each disease by dividing the median expression of  that probe in 
that disease by the median expression of  that same probe across the disease subtypes. Thus, ranking probes 
by their proportional median measures the relative expression in one subtype compared with all others.
Cell-type deconvolution by specific immune signatures. In order to be able to connect specific genes that comprise 
the leprosy subtype signatures with immune cell types, a deconvolution analysis was performed. Cell-type–spe-
cific signatures were previously developed by Swindell et al. (20, 21) by comparing relative gene expression fold 
changes for a set of publicly available microarray data, which was selected as being representative of specific 
cell types. Briefly, the 50 genes most enriched for each cell type were identified using moderated t tests and fold 
changes (20, 21). Scores for each cell-type signature were assessed in disease subtype gene expression profiles 
by computing log intensities of the genes in that subtype relative to all others and then calculating an arithmetic 
mean of the log expression gene specificity to a certain cell type. Scores were then grouped by hierarchical 
clustering according to Euclidian distance (Figure 2A). The signatures for CD3+, CD4+, and CD8+ T cells were 
prominent in T-lep and RR lesions, albeit not significantly enriched compared with the other leprosy subtypes. 
The DC signature was strongest in T-lep lesions, consistent with the role of DC in activating T cell responses 
as part of cell-mediated immunity in T-lep patients. A keratinocyte signature was found to be enriched in T-lep 
lesions (Z score = 2.2). These data correlate with classical histopathological observations that T cells are abun-
dant in T-lep and RR lesions (4, 22) and that keratinocytes in T-lep lesions express high levels of MHC class 
Figure 3. Identification of clinical 
subtype gene modules in leprosy 
patients. Correlation of WGCNA modules 
to leprosy subtypes was calculated by 
correlating module eigengene expression 
to a binary matrix representation of 
sample membership for each particular 
subtype. Module eigengenes, as well as 
the corresponding number of genes in 
each module, are labeled on the y axis, 
and leprosy subtypes are labeled on the 
x axis. Each square in the heatmap is 
colored according to correlation, with P 
values for correlation given in parenthe-
ses. ENL, erythema nodosum leprosum; 
L-lep, lepromatous leprosy; RR, reversal 
reaction; T-lep, tuberculoid leprosy.
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II, a sign of immune activation (23). Deconvolution of the L-lep gene expression profile identified a significant 
signature score for macrophages (Z score = 3.2) and a prominent enrichment for CD138+ plasma cells, both of  
which are indeed prominent in lesions (24), consistent with the elevated antibody levels in L-lep patients. Final-
ly, ENL lesions were characterized by gene signatures for vascular and lymphatic endothelial cells as well as 
Figure 4. Integration of WGCNA gene modules with cell-type–specific gene signatures. For each of the 17 modules of 
related genes derived from WGCNA analysis, enrichment for cell-type–specific gene signatures for 18 cell types with 
immune or structural functions were calculated and displayed in a heatmap of Z scores. Z scores were calculated from 
log2 fold change enrichment scores, using average gene expression for each leprosy subtype for each cell type. Cell-type 
names are provided in rows, and WGCNA module names from Figure 2 are provided in the column. Modules that were 
significantly associated with one leprosy subtype are labeled. ENL, erythema nodosum leprosum; L-lep, lepromatous 
leprosy; RR, reversal reaction; T-lep, tuberculoid leprosy.
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neutrophils, consistent with the pres-
ence histologically of a neutrophilic 
vasculitis. The strong keratinocyte 
signature in ENL lesions  (Z score = 
1.9) is also consistent with their robust 
expression of MHC class II in the epi-
dermis overlying ENL lesions (23).
A similar analysis of  the pro-
portional median gene lists for each 
subtype identified enrichment for 
specific cell types and genes of  sig-
nificance to immune pathogenesis 
(Figure 2B). In the T-lep proportion-
al median list, DC were enriched 
(6 of  50 genes, including MMP12, 
CD1B, and CD1C, P = 0.002). Mac-
rophages were enriched in L-lep 
lesions, including the genes associ-
ated with the M2 macrophages in 
L-lep lesions (25) (14 of  50 genes, 
including MARCO and MSR1, P = 5 × 10–11), as were CD138+ plasma cells (5 of  50 genes, including IGHD 
and TNFSFR17, P = 0.01). The top proportional median gene in L-lep lesions was CHRNA1, the cholin-
ergic receptor nicotinic α 1 subunit. Although this gene was not connected to the cell-type signatures or 
any of  the pathways analyses, it has been shown to contribute to macrophage-induced inflammation in 
atherosclerosis (26, 27), in addition to its established function at the neuromuscular junction (28). The role 
of  CHRNA1 in microbial pathogenesis is unknown. In ENL lesions, a fibroblast gene signature was found 
to be enriched (6 of  50 genes, including MMP3, P = 0.001).
Cell-type deconvolution of  disease-specific gene modules by weighted gene correlation network analysis. In order 
to identify genes and functional pathways associated with leprosy subtypes, we performed weighted gene 
correlation network analysis (WGCNA) on the filtered leprosy gene expression profiles (29, 30). WGCNA 
is a clustering approach that identifies the typical pattern of  each cluster (the eigengene). The WGCNA 
algorithm uses correlations to group genes into modules, similar to traditional clustering analysis; unlike 
other approaches, it raises each correlation to a power, thus lending more weight to stronger, more reli-
able correlations. We then correlated these patterns with binary vectors that encode each subtype (i.e., a 
sample is assigned a 1 if  it is part of  the subtype and 0 if  not). Therefore, a significant module-subtype 
Figure 5. Specific networks for clinical 
subtypes of leprosy (L-lep and ENL). 
Gene ontology, KEGG pathway, and 
Reactome analysis were performed 
with ClueGO (Cytoscape software) for 
the most relevant WGCNA modules and 
the top 250 genes of the proportional 
median (PM) list for each leprosy clinical 
subtype. Genes selected from gene sets 
composed of either PM lists or WGCNA 
modules were overlapped with the top 
250 genes in the specific cell-type signa-
tures related with (A) L-lep and (B) ENL. 
Connections were visualized by Gephi 
software. Blue circles represent genes, 
red circles denote immune functions, yel-
low circles show cell type, and gray lines 
represent connections between genes 
and immune functions and/or cell types. 
ENL, erythema nodosum leprosum; 
L-lep, lepromatous leprosy.
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correlation implies that samples from one specific subtype have higher expression than those of  other 
subtypes. WGCNA analysis identified 17 modules of  coexpressed genes (Figure 3, y axis). To determine 
which modules were associated with each disease subtype, we performed module eigengene correlation 
of  the samples clustering within the main subtype branch by coding traits as a binary matrix of  zeros 
and ones: each sample had a value of  “1” for its corresponding subtype and a value of  “0” for all other 
subtypes (30).
The “purple” module was significantly correlated to T-lep (correlation = 0.41; P = 0.03). The “tan” 
module was significantly correlated to RR (correlation = 0.43, P = 0.02). Four modules, “gray60,” 
“brown,” “salmon,” and “cyan” were significantly correlated to L-lep (correlation = 0.7, 0.85, 0.55, and 
0.45; P = 2 × 10–5, 5 × 10–9, 0.002, and 0.01, respectively). Five modules, “magenta,” “black,” “blue,” 
“red,” and “turquoise,” were significantly correlated to ENL (correlation = 0.38, 0.75, 0.47, 0.48, and 
0.82; P = 0.04, 2 × 10–6, 0.01, 0.009 and 5 × 10–8, respectively).
The WGCNA modules were next evaluated by cell-type deconvolution to identify the specific immune 
cells that contribute to specific genes and the correlated networks (Figure 4). The “purple” T-lep module 
overlappedkeratinocytes (5 of  50 genes) and DC (2 of  50 genes, including MMP12 and CCL22). The “tan” 
module associated with RR did not significantly overlap with a specific cell-type signature. For the L-lep 
modules, the “brown” module overlapped with macrophages (28 of  50 genes, including MSR1, CHIT1, 
ATP6V0D2, MARCO, and TREM2, P = 2.7 × 10–8), monocytes (8 of  50 genes, including TLR5, TLR7, 
NLRP3, CD14, CD33, and DENND1A), and B cells (7 of  50 genes, including CD22), with “gray60” over-
lapped with CD138+ plasma cells (6 of  50 genes, including TNFRSF17, MZB1, and IGHD, P = 3.7 × 10–4). 
The “brown” module also overlapped with the DC signature. For the ENL modules, the “black” module 
overlapped with the cell-type signatures for vascular and lymphatic endothelial cells (5 of  50 and 4 of  50 
genes, respectively) as well as fibroblasts (11 of  50 genes, P = 2.7 × 10–2). In addition, the “turquoise” mod-
ule overlapped with many other cell-type signatures, including vascular endothelial cells (5 of  50 genes, P = 
2.0 × 10–3) and lymphatic endothelial cells (9 of  50 genes), fibroblasts (8 of  50 genes), and neutrophils (3 of  
50 genes). Although not statistically significant, this overlap for neutrophils was greater than that any other 
module, consistent with the characteristic presence of  neutrophils in ENL lesions. Overall, there was high 
concordance for the cell types identified by deconvolution of  the subtype-specific proportional median sig-
natures and the corresponding subtype-specific WGCNA modules. These results suggest that the clustering 
pattern of  expression profiles across disease subtypes is dictated in part by the cell-type–specific expression 
of  genes, with genes highly expressed in certain cell types concentrated within particular modules.
Integrative analysis reveals gene pathways associated with leprosy subtypes. To define gene networks for each 
disease subtype, we used WGCNA to identify coexpression relationships and integrated the information 
from functional pathways and cell-type deconvolution analysis with an analysis of  the subtype-defined 
proportional median genes. In L-lep lesions, integration of  the functional pathway analysis of  the “brown” 
and “gray60” modules as well as the top 250 proportional median genes identified pathways relating to 
macrophage function, including “phagosomes,” “endocytosis,” and “endosomes” as well as “lipid bind-
ing,” which by the deconvolution analysis was connected with the macrophage and monocyte signatures. 
In addition, a number of  immunoglobulin genes were connected to “innate immunity” and “receptor sig-
naling/activity,” which, in turn, connected with the plasma cell and B cell signatures in the deconvolution 
analysis (Figure 5A).
We noted in the gene set containing the “black” and “turquoise” modules as well as the ENL pro-
portional median list, a collection of  genes encoding collagen polypeptides associated with extracellular 
matrix organization. Gene pathways for “angiogenesis” and “vasculature development” were prominent, 
reflecting the vascular and lymphatic endothelial cell as well as the fibroblast signatures detected by cell-
type deconvolution. The “cell migration,” “chemotaxis,” and “cell motility” pathways were related to the 
neutrophil gene signature identified by cell-type deconvolution (Figure 5B).
To identify genes differentially associated with RR, we overlapped the top 250 proportional median 
genes with “tan” module gene set. Functional analysis identified pathways related to nerve biology, 
including “response to IFN-γ,” which included CYP27B1, part of  the vitamin D antimicrobial pathway, 
which was also identified in the proportional median genes in T-lep lesions (Figure 6A). In RR, gene 
pathways for “neurogenesis,” “neurotrophin signaling pathway,” “axon guidance,” and “glial cell differ-
entiation” were detected. Gene pathway analysis further identified immune networks related to cell death 
and cell survival, including “apoptosis,” “response to stress,” and “autophagy.” The intersection of  gene 
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pathways involved in nerve 
biology and immune-me-
diated cell death and cell 
survival reflects the process 
of  immune-mediated nerve 
injury in RR.
The gene pathways that 
are involved in T-lep were 
examined by integrating the 
WGCNA “purple” mod-
ule, associated with T-lep, 
alongside the top 250 pro-
portional median genes for 
T-lep (Figure 6B). The top 
proportional median gene 
in T-lep was matrix metal-
loproteinase-12 (MMP12), which was connected in both comparisons to the “response to wounding,” 
“chemotaxis,” “cell proliferation,” and “tissue morphogenesis” pathways. MMP12 was also connected 
to DC by the deconvolution analysis.
Gene expression and tissue immunolabeling of  leprosy skin lesions show higher expression of  MMP12 in T-lep 
versus L-lep. MMP12 was the gene with the highest proportional median value in the T-lep lesions. As a 
result, we evaluated MMP12 mRNA expression in our leprosy subtype gene expression profiles as well 
as additional samples collected at a different time. These samples comprised 13 previously published 
ENL (n = 6) and L-lep (n = 7) samples (14) and 9 newly obtained L-lep (n = 3), RR (n = 3), and T-lep (n 
= 3) gene expression profiles derived from deidentified leprosy skin biopsy specimens, for a total of  51 
gene expression profiles. MMP12 mRNA expression was significantly higher in the T-lep lesions in com-
parison to that in the L-lep and ENL lesions (P < 0.01 for each, Figure 7). The expression of  MMP12 
mRNA in RR was variable and statistically indistinguishable from the other samples, albeit somewhat 
lower than in T-lep lesions, with strong expression in only 4 of  10 RR samples as compared with 9 of  
13 T-lep samples. MMP-12 protein was detected by immunohistochemistry and was also more highly 
expressed in T-lep and RR lesions, as compared with L-lep or ENL lesions (Figure 8). MMP-12 protein 
expression was strong throughout the granuloma but was also detected in cells with elongated nuclei, 
presumably fibroblasts, in the connective tissue (Figure 8A). Quantification of  MMP-12 expression in 
Figure 6. Specific networks for clinical 
subtypes of leprosy (T-lep and RR). 
Gene ontology, KEGG pathway, and 
Reactome analysis were performed 
with ClueGO (Cytoscape software) for 
the most relevant WGCNA modules and 
the top 250 genes of the proportional 
median (PM) list for each leprosy clinical 
subtype. Genes selected from gene sets 
composed of either PM lists or WGCNA 
modules were overlapped with the top 
250 genes in the specific cell-type signa-
tures related with (A) RR and (B) T-lep. 
Connections were visualized by Gephi 
software. Blue circles represent genes, 
red circles denote immune functions, 
yellow circles show cell type, and gray 
lines represent connections between 
genes and immune functions and/
or cell types. (A) RR function analysis 
shows genes (blue circles) connected 
with immune and neural biology (red) 
functions. RR, reversal reaction; T-lep, 
tuberculoid leprosy.
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skin lesions by automated image analysis showed that T-lep lesions have 
significantly higher expression of  MMP-12 compared with L-lep and ENL 
samples (P < 0.001 and P < 0.01, respectively). RR lesions were character-
ized by a lower expression of  MMP-12 compared with T-lep lesions (not 
significant) but a significantly higher expression level when compared with 
L-lep lesions (P < 0.05) (Figure 8B).
Discussion
The disease spectrum of  leprosy provides an extraordinary model to investigate the relationship between 
the immune response at the site of  infection and the clinical presentation and in particular to understand 
the gene networks that contribute to host defense versus immunopathology. Here, integration of  cell-type 
deconvolution with the functional pathways associated with the proportional median lists and the coex-
pression gene networks for each disease subtype revealed new and distinct immune mechanisms at the 
site of  disease. For example, it was unanticipated that this approach would identify an integrated network 
involving DC linked to MMP12 as part of  tissue remodeling and inflammation functional programs in T-lep 
lesions, in which the infection is contained. In the other forms of  leprosy, gene networks that are known to 
contribute to host defense and tissue injury were identified, including those pertinent to IFN-γ responses, 
nerve injury, and vasculitis. The present integrated computational approach provides a systems approach 
toward identifying cell-defined functional networks at the site of  disease.
In T-lep lesions, the top proportional median gene was MMP12, an elastase, suggesting a key role for tissue 
remodeling in the host defense response to M. leprae. We demonstrated that the MMP-12 protein was more high-
ly expressed in T-lep and RR lesions versus L-lep and ENL lesions, as is most evident throughout the granulo-
matous infiltrate. MMP12 and its coexpressed genes were linked to “response to wounding,” “chemotaxis,” “cell 
proliferation,” and “tissue morphogenesis” pathways. In DC, MMP-12 is induced by a combination of inflam-
matory cytokines, including TNF-α, IL-1β, IL-6 and GM-CSF (31). MMP-12 is also known to be expressed 
in monocytes, macrophages, and fibroblasts. Like other matrix metalloproteinases, MMP-12 is involved in the 
breakdown of the extracellular matrix. Although the major substrate for MMP-12 is elastin, MMP-12 is able 
to degrade a broad spectrum of substrates, such as type IV collagen, fibronectin, laminin, vitronectin, proteo-
glycans, chondroitin sulfate, α-1-antitrypsin, plasminogen, and myelin basic protein, which is related to nerve 
damage in the disease (32). MMP-12 contributes to cell migration (33) of DC and leukocytes (31, 34). The 
ability of MMP-12 to cleave off IFN-α receptor 2–binding sites (35) blocks the action of type I IFN, which in 
previous work we showed blocks antimicrobial responses in leprosy (16). The presence of MMP-12 in T-lep and 
RR granulomas, as well as other granulomatous diseases such as sarcoidosis (36), suggests that MMP-12 is part 
of a tissue remodeling and inflammation gene network that contributes to granuloma formation and/or main-
tenance. The induction of MMP-12 in RR lesions indicates the dynamic upregulation of this protein during the 
clinical reduction in the bacillary load and gain in immunity.
The identification of MMP-12 as a contributor to the local immune response in mycobacterial infection 
was unexpected, since previous studies have focused on the role of a different metalloproteinase family mem-
ber, MMP-9. In addition to MMP-12, MMP-9 was also present in the top T-lep proportional median genes, 
more highly expressed in T-lep, RR, and L-lep versus ENL. Previously, MMP-9 protein was found to be more 
highly expressed in T-lep versus L-lep lesions (37), including in Schwann cells (38), and could be induced by 
M. leprae in cultured Schwann cells (39). In Mycobacterium marinum infection of zebrafish, studied as a model 
for human tuberculosis, MMP-9 has been shown to be required for granuloma formation (40). MMP-9 and 
MMP-12 cooperate in tissue remodeling in the lung (41) and may coregulate, as MMP-12 upregulated MMP-9 
expression in the presence of IL-1β (42). In the gene networks in T-lep lesions, MMP9 and MMP12 were connect-
ed by the common gene ontology terms: “chemotaxis” and “tissue remodeling”. As part of this network, other 
Figure 7. MMP12 regulation in leprosy. Distribution of MMP12 mRNA by microarray 
analysis of skin lesions shown in arbitrary units (AU). The graph shows the total 
number of samples per clinical subtype (mean and SEM). Data represent mean ± 
SEM, RR = 10 (457.2 ± 207.2 AU), T-lep = 13 (732.7 ± 186.3 AU), L-lep = 16 (143.2 ± 54.41 
AU), and ENL = 12 (186.3 ± 138.6 AU). Significance was determined by Kruskal-Wallis 
test (nonparametric ANOVA style test) using GraphPad Prism software and post-hoc 
analysis (Dunn’s multiple comparison test). **P < 0.01. ENL, erythema nodosum lep-
rosum; L-lep, lepromatous leprosy; RR, reversal reaction; T-lep, tuberculoid leprosy.
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genes involved in “chemotaxis” and “tissue remodeling” included IRF6, ADIPOQ, OVOL1, and FOXQ1 (43–48). 
Another prominent gene, CYP27B1, a member of the cytochrome p450 family, is a critical part of the vitamin 
D antimicrobial pathway to kill mycobacteria (16, 25, 49, 50). Together, these networks link chemotaxis, tissue 
remodeling, and antimicrobial activity as part of the effective host response to limit mycobacterial infection.
Our previous studies failed to identify specific gene networks associated with RR lesions (16). However, 
here, we analyzed the gene expression profiles in RR patient lesions by integrating the top proportional 
median genes and the WGCNA “tan” module, which was most highly correlated with RR. Gene networks 
related to cell death and nerve biology were identified. Genes associated with neuronal death and subse-
quent regeneration (LIFR, BCL11A, AATK, BCL2L11, GSK3A, PLCG1) suggest an ongoing cycle of  axon 
degradation and regeneration. Specifically, these gene signatures are indicative of  neurotrophin signaling 
through Trk and p75 receptors, reflecting the essentiality of  this pathway for vertebrate neuronal mainte-
nance (51). In addition, EGFR (also known as ERBB1) and ERBB3, found in these lesions, are part of  the 
ErbB family, which has been shown to be critical for Schwann cell differentiation and survival (52). Genes 
involved in cell death included TNFSF10 (also know as TRAIL), CXCR3, CCL19, and IDO, which regulate 
apoptosis (53–56), consistent with the prominent apoptosis present in RR lesions in comparison to nonre-
actional patients (57, 58). We previously demonstrated that M. leprae ligands induce apoptosis of  Schwann 
cells through TLR2, providing one mechanism by which activation of  the innate immune response con-
tributes to nerve injury in leprosy (59). The immune pathway “response to IFN-γ” was associated with RR 
lesions, including the genes that contribute to antimicrobial activity, including CCL19, CYP27B1, and GBP5. 
Together, those pathways provide insight into clinical presentation of  RR, characterized as sudden episodes 
Figure 8. MMP-12 expression in leprosy lesions. MMP-12 protein expression was evaluated in leprosy lesions (T-lep, L-lep, RR, and ENL). (A) CD3 expres-
sion was used as a marker for T cells, and IgG1 was used as a negative control; 1 representative labeled section is shown of at least 5 (each obtained from 
a different patient). Scale bar: 40 μm. Original magnification: ×100. (B) Automated image analysis of MMP12 protein expression. Each dot represents the 
percentage of MMP-12–stained area (diaminobenzidine [DAB]) per nuclear area for each individual photomicrograph (n = 5 for each group). Data represent 
mean ± SEM, T-lep (77.5 ± 10.7), L-lep (17.8 ± 8), RR (54.76 ± 10.2), and ENL 13 (32.14 ± 10.2). One-way ANOVA analysis was performed (P = 0.0004) using 
GraphPad Prism software, and post-hoc analysis (Bonferroni test) is indicated (*P < 0.05, **P < 0.01, ***P < 0.001). ENL, erythema nodosum leprosum; 
L-lep, lepromatous leprosy; RR, reversal reaction; T-lep, tuberculoid leprosy.
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of  inflammation, edema, and neuritis, associated with severe peripheral nerve impairment and disabilities 
associated with enhanced immunity against M. leprae (60–62).
In L-lep lesions, gene networks linked to macrophages and B cells were defined that clearly relate to 
the clinical presentation of  these patients. Networks of  genes involved in “endocytosis,” “lysosome,” and 
“phagosome” were identified and associated with macrophages, possibly reflecting the presence of  IL-10–
derived CD163+ M2 macrophages, which are programmed to be highly phagocytic (16, 25). A lipid-binding 
pathway was present in L-lep lesions, which is consistent with the observation that host-derived lipids 
accumulate in macrophages in L-lep lesions (63). Genes involved in humoral immunity, including IGAH1, 
IGHM, and IGJ genes, which encode the protein components forming IgA and IgM multimers, were prom-
inent in L-lep lesions, consistent with the previous identification of  B cell genes in L-lep lesions (24, 64). 
These Ig genes were connected to B cells and plasma cells, which are present at a greater frequency in L-lep 
lesions versus T-lep lesions (24, 65). We previously found that IgA and IgM mRNA and protein were more 
strongly expressed in L-lep lesions versus T-lep lesions, with IgM colocalizing with CD138+ plasma cells 
(24). These data support the dogma that humoral immune responses found in the L-lep disease do not 
contribute to effective host defense against M. leprae infection but could contribute to disease pathology.
ENL occurs in patients toward the L-lep part of  the disease spectrum, presenting as a neutrophilic vas-
culitis and panniculitis. Previously, we had identified the gene pathways involved in neutrophil recruitment 
in ENL lesions (14). Here, we defined CXCL1, CXCL5, and CCR2 as associated with a neutrophil signa-
ture and linked with a “chemotaxis” gene network in ENL lesions. In addition, the present data defined 
“angiogenesis” and “vascular development” gene networks in ENL lesions, consistent with the histological 
prominence of  new blood vessel formation in ENL (66). In particular, these analyses identified genes like 
ROBO4, NOTCH1, HEY1, SEMA5A, and WNT5A, which are indicative of  active angiogenesis. The ENL 
signature identified here was consistent with vascular remodeling events, as per the high number of  matrix 
proteins, and the maturation and organization of  pericyte-endothelial interactions. The high frequency 
of  matrix proteins that are either integral components of  the basement membrane (COL4A1, COL8A1, 
LAMA5) or frequently associated with blood vessels indicates that this tissue is actively engaged in either 
repairing and/or supporting the establishment of  a newly formed vascular tree. Genes associated with late 
responses to inflammatory events were also represented (IL6, CXCL12) as well as a subgroup of  genes that 
is required for the active engagement of  endothelial-pericyte/smooth muscle cell interactions (PDGFA, 
PDGFRB, NOTCH3, CYR61), also indicative of  vascular maturation. The clinical response of  ENL patients 
to the drug thalidomide has been related to its ability to inhibit angiogenesis (67).
In this work, we found that two key measures of  disease-specific gene expression profiles, the propor-
tional median and the WGCNA module, could be analyzed and integrated to identify disease mechanisms. 
By cell-type deconvolution of  the proportional median list and disease-related WGCNA module, along 
with gene ontology analysis, it was possible to link cell types with functional pathways to identify the 
gene networks that contribute to the clinical manifestations of  disease as well as pathophysiologic disease 
mechanisms. Using this approach, we indicated that DC are linked to MMP12 and a tissue remodeling 
network that contributes to host defense at the site of  infection in leprosy. We also identified several path-
ways involved in pathogenesis and tissue injury, such as neutrophil and endothelial cell gene networks that 
contribute to chemotaxis and angiogenesis, respectively, in ENL. Delineation of  cell-related functional net-
works can enhance our understanding not only of  leprosy but of  other diseases with a complex immuno-
logical component and offer greater possibilities than previous work in identifying targets for host-directed 
therapy in human infectious diseases.
Methods
Microarray normalization and clustering. Skin lesional biopsy specimens were obtained from patients with 
various multidrug therapy treatment duration (Tables 1 and 2) and included the following leprosy sub-
types: L-lep (n = 6), T-lep (n = 10), RR (n = 7), and ENL (n = 6). Although obtained simultaneously with 
the ENL profiles, the T-lep, L-lep, and RR gene expression profiles were previously published (15). All 
L-lep samples were classified according to the Ridley-Jopling criteria as lepromatous (LL), and most of  
T-lep patients were classified as borderline tuberculoid (BT); only one of  them was classified as border-
line (BB) (Table 1). For RR, 4 patients were classified as borderline lepromatous (BL) patients at the time 
of  diagnosis, 2 patients were classified as BT, and 2 patients classified as BB or BT/BB. Most of  the RR 
occurred during chemotherapy. In most of  the RR patients, the bacillary index was positive, except for 2 
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patients with bacillary index of  0.5 (Table 2). All ENL patients had received multidrug therapy and were 
classified at the time of  diagnosis as LL, 3 patients developed ENL after completion of  multidrug ther-
apy, and 3 developed ENL during multidrug therapy (Table 2). All skin biopsy specimens from patients 
with one of  the reactional states were biopsied at the site of  reaction, at the time of  diagnosis of  RR 
or ENL, and before start of  additional chemotherapy. Some of  the RR and ENL patients presented in 
reaction before chemotherapy, and others developed their reactional state during chemotherapy. mRNA 
was extracted from lesions, and gene expression profiles were derived via Affymetrix HG U133 Plus 2.0 
microarrays (Affymetrix) and normalized using fRMA, as previously described in Bleharski et al. (64). 
Test samples were obtained from publicity available data on NCBI GEO (GSE17763 for 10 T-lep, 6 LL, 
and 7 RR samples and GSE8489 for ENL samples). Additional data for validation of  MMP-12 gene 
expression were obtained from publicly available data on NCBI GEO (GSE16844; L-lep: n = 7; and 
ENL: n = 6) (14) (validation set “V1”) and a second batch of  skin lesional biopsy specimens (L-lep: n = 3; 
T-lep: n = 3; RR: n = 3) (validation set “V2”); both sets were derived via Affymetrix HG U133 Plus 2.0 
microarrays. All data were normalized using fRMA to minimize between-batch variation (68). Samples 
were deposited in GEO under numbers GSE17763 and GSE16844
Normalized data were filtered at a mean intensity of  at least 150 in any one subtype. Filtered data 
were used in the proportional median signature, PCA, clustering, and WGCNA analyses. For the PCA 
analysis, genes were further filtered using a coefficient of  variance of  ≥ 1.0 and PCA was performed using 
Partek v6.4. Hierarchical clustering of  genes with a mean intensity of  ≥ 150 was performed using average 
correlation distances and the “amap” package in R.
Proportional median signatures. The proportional median metric was defined as the median intensity of  
a probe set within one leprosy subtype divided by the median intensity of  the same probe set across all 
samples. Proportional median values were calculated for each subtype and ranked according to highest 
proportional median as previously described (15).
Cell-type–specific signature enrichment. Cell-specific enrichment was calculated using an adapted method-
ology from Swindell et al. (21). Using 50 gene signatures for each cell type, signature scores were calculated 
for each subtype based on the mean score of  the log-transformed, mean-centered values. The scores for 
each signature were then clustered based on average Euclidian distance.
WGCNA. WGCNA was performed on the filtered leprosy subtype gene expression profiles (“wgc-
na” package in R). Automatic network construction was carried out with a power of  14 and a minimum 
module size of  50. For each module, networks were constructed using the topological overlap matrix. 
The top 50 probes from each network were selected by filtering using kME (intramodular connectivity) 
Table 1. Clinical characteristics of leprosy patients
Patient R&J classificationA Bacillary index Age (yr) Gender Ethnic group Nationality
LL1 LL 4 41 M White Brazilian
LL2 LL 4 46 F White Portuguese
LL3 LL N/A 58 M Hispanic Mexican
LL4 LL 4.66 23 M White Brazilian
LL5 LL 4.33 26 M Mixed Brazilian
LL7 LL 4 40 F Asian Phillipina
TL1 BT 0 43 M Mixed Brazilian
TL2 BB 2.83 18 M White Brazilian
TL3 BT 0 26 M Mixed Brazilian
TL4 BT 0 64 M Mixed Brazilian
TL5 BT 0 38 F White Brazilian
TL6 BT 0 N/A M N/A Brazilian
TL7 BT 0 33 M Mixed Brazilian
TL8 BT 0 25 M Mixed Brazilian
TL9 BT 1.83 28 M White Brazilian
TL10 BT N/A 30 M N/A N/A
ARef. 4. BB, borderline; BT, borderline tuberculoid; LL, lepromatous.
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and converted to gene names before displaying. Networks were built using VisANT (69). Module cor-
relation to leprosy subtypes was calculated by computing the correlation of  each module eigengene to 
a binary matrix of  traits, which corresponded to individual subtypes (30). Correlation and significance 
calculations, as well as heatmap display, were calculated using built-in functions from the “wgcna” R 
package. P values for overlap of  modules with cell-type–specific signatures were calculated using the 
hypergeometric distribution and were corrected using a Bonferroni adjustment (n = 16).
Functional analysis. Gene ontology, KEGG pathway, and Reactome analysis were performed with Cyto-
scape (ClueGO application) with Bonferroni correction for proportional median signatures, cell-specific 
signatures, and WGCNA modules. Gephi software was used to visualization of  functional networks.
Tissue immunostaining. For each leprosy subtype, 5 leprosy skin biopsies (from 5 different patients) 
were prepared, from which 1 representative sample was selected. Frozen tissue sections were blocked 
with normal horse serum before incubation with MMP-12 (clone 4D, R&D Systems, MAB917), CD3 
(clone SK7, BD Bioscience, 340851) monoclonal antibodies, and isotype control (clone MOPC 21, 
Sigma-Aldrich, M5284) for 60 minutes, followed by incubation with biotinylated horse anti-mouse IgG 
(Vector Laboratories, B-2000) for 30 minutes (70). Slides were counterstained with hematoxylin and 
mounted in crystal mounting medium (Biomeda) and were visualized using the ABC Elite system (Vec-
tor Laboratories). Skin sections were examined using a Leica microscope (Leica 2500). Expression of  
MMP-12 in photomicrographs was quantified using ImmunoRatio, an automated image analysis appli-
cation, blind to the diagnosis, which calculates the percentage of  diaminobenzidine-stained nuclear 
area per total area (71). This application was developed based on ImageJ quantification, and it is part 
of  the ImageJ plug-ins.
Statistics. Statistical methods for specific analyses are detailed in paragraphs above. In brief, microar-
rays were normalized with the fRMA method (“frma” R package) (63). Microarray clustering was per-
formed using hierarchical clustering with average Euclidian distance, and microarray module-finding 
analysis was carried out by weighted gene coexpression analysis (“wgcna” R package) (23). P values for 
module overlap with cell-type–specific signatures were calculated using a Bonferroni-corrected hyper-
geometric distribution. For MMP12 gene expression and MMP-12 protein expression, multiple compar-
ison tests were used for statistical analysis. They were selected based on normal distribution analysis; 
tests and P values are listed in the figure legends. P values of  less than 0.05 were considered significant.
Study approval. Ethical approval for the use of  human leprosy biopsy specimens was obtained 
from the UCLA Institutional Review Board. Written informed consent was obtained from all 
patients included in the study.
Table 2. Clinical characteristics of leprosy patients with reaction
Patient Initial R&J 
classificationA
Bacillary index Age (yr) Gender Reaction Ethnic group Nationality Time to 
reactionB 
(months)
RR1 BL 4.16 67 F RR White Brazilian 20
RR2 BB 4.25 17 M RR Black Brazilian 2
RR3 BT/BB 0.5 41 F RR Mixed Brazilian 1
RR4 BL 0.5 54 M RR Mixed Brazilian 0
RR5 BL 2.6 18 M RR Mixed Brazilian 2
RR6 BT 2.83 50 M RR White Brazilian 24
RR7 BL 2.5 19 M RR White Brazilian 16
ENL1 LL 2.83 32 M ENL White Brazilian 23
ENL2 LL 0 60 F ENL Mixed Brazilian 8
ENL3 LL 2.83 32 M ENL White Brazilian 24
ENL5 LL 2.66 26 M ENL Black Brazilian 20
ENL7 LL 4.16 20 M ENL White Brazilian 1.5
ENL8 LL N/A 22 M ENL Hispanic Mexican 2
ARef. 4, classification before reaction episode. BDuration between first dose of multidrug therapy and reaction episode. BB, borderline; BL, borderline 
lepromatous; BT, borderline tuberculoid; ENL, erythema nodosum leprosum; LL, lepromatous; RR, reversal reaction. 
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